Battelle Showcases Biosecurity and Biotechnology Capabilities to NSCEB
Event summary
- Battelle hosted members of the National Security Commission on Emerging Biotechnology (NSCEB) at its Columbus headquarters on August 6, 2026.
- The visit included panel discussions and laboratory tours focused on biosecurity, emerging biological threats, and supply chain resilience.
- Key participants included Alina Meltaus, Chief of Staff of NSCEB, and Greg Kimmel, Vice President and General Manager of Battelle's Health business.
- NSCEB's District Spotlight series aims to inform congressional recommendations on biotechnology, supply chains, and national security.
The big picture
Battelle's engagement with NSCEB underscores the growing intersection of biotechnology and national security. The event highlights Ohio's emerging role in the biotech sector, driven by collaborations between industry, government, and academia. As the U.S. seeks to strengthen its competitiveness and supply chain resilience, such partnerships will be critical in shaping future policy and investment.
What we're watching
- Government Collaboration
- How NSCEB's recommendations will influence federal funding and policy for biotechnology and national security.
- Regional Ecosystem Growth
- Whether Ohio can sustain its position as a biotechnology hub through continued public-private partnerships.
- Technological Deployment
- The pace at which Battelle and its partners can transition laboratory innovations into scalable national capabilities.